Inhibrx Biosciences, Inc. (INBX) stock
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$69.06−5.12 (-6.90%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Inhibrx Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Inhibrx Biosciences's market cap was $1.33B on Nov 11, 2026, against $1.22B a year earlier. Over the last 5 years it ranged from $110.74M to $1.88B, with a median of $245.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.33B | +16.3% |
| 2025 | Dec 31, 2025 | $1.15B | +413.8% |
| 2024 | Dec 31, 2024 | $222.93M | -50.4% |
| 2023 | Dec 29, 2023 | $449.26M | +86.6% |
| 2022 | Dec 30, 2022 | $240.78M | -41.9% |
| 2021 | Dec 31, 2021 | $414.13M | +33.2% |
| 2020 | Dec 31, 2020 | $310.83M | – |
See a number that looks wrong?